Life Spine’s Long Bow System Nabs FDA Clearance

Life Spine has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Long Bow Expandable Lateral Interbody System.

According to the company, the Long Bow device is the first interbody system on the market that expands laterally in situ specifically for a direct lateral approach.

“With the Long Bow interbody system, surgeons can decrease the amount of retraction by as much as 45 percent compared to current lateral systems. The benefits are transferred directly to the patient by minimizing tissue retraction and potential nerve damage associated with the lateral access approach,” said Richard Greiber, vice president of business development and professional relations for Hoffman Estates, Ill.-based LIfe Spine.

The system is scheduled for limited release at the end of this year with full product release expected in the first quarter of 2015.